tiprankstipranks
Trending News
More News >
Enzon Pharmaceuticals (ENZN)
OTHER OTC:ENZN
US Market
Advertisement

Enzon Pharmaceuticals (ENZN) Technical Analysis

Compare
90 Followers

Technical Sentiment

Overall Consensus
Sell
4Bullish
4Neutral
13Bearish
Technical Analysis Consensus
Buy
4Bullish
4Neutral
1Bearish
Moving Average Consensus
Strong Sell
0Bullish
0Neutral
12Bearish
Enzon Pharmaceuticals’s (ENZN) Moving Averages Convergence Divergence (MACD) indicator is <0.01, suggesting Enzon Pharmaceuticals is a Buy.
Enzon Pharmaceuticals’s (ENZN) 20-Day exponential moving average is 0.08, while Enzon Pharmaceuticals’s (ENZN) share price is <$0.1, making it a Sell.
Enzon Pharmaceuticals’s (ENZN) 50-Day exponential moving average is 0.09, while Enzon Pharmaceuticals’s (ENZN) share price is <$0.1, making it a Sell.

Enzon Pharmaceuticals (ENZN) Pivot Points

Sep 13, 2025, 06:09 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
0.07
0.08
0.08
0.08
0.08
0.09
0.09
Fibonacci
0.08
0.08
0.08
0.08
0.08
0.08
0.09
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Enzon Pharmaceuticals (ENZN) Moving Averages

Sep 13, 2025, 06:09 PM
Period
Simple
Exponential
MA5
0.08Sell
0.08Sell
MA10
0.09Sell
0.08Sell
MA20
0.08Sell
0.08Sell
MA50
0.09Sell
0.09Sell
MA100
0.09Sell
0.09Sell
MA200
0.11Sell
0.10Sell
Enzon Pharmaceuticals’s (ENZN) 10-Day exponential moving average is 0.08, while Enzon Pharmaceuticals’s (ENZN) share price is <$0.1, making it a Sell.
Enzon Pharmaceuticals’s (ENZN) 100-Day exponential moving average is 0.09, while Enzon Pharmaceuticals’s (ENZN) share price is <$0.1, making it a Sell.
Enzon Pharmaceuticals’s (ENZN) stock price is <$0.1 and Enzon Pharmaceuticals’s (ENZN) 50-day simple moving average is 0.09, creating a Sell signal.
Enzon Pharmaceuticals’s (ENZN) stock price is <$0.1 and Enzon Pharmaceuticals’s (ENZN) 100-day simple moving average is 0.09, creating a Sell signal.
Enzon Pharmaceuticals’s (ENZN) stock price is <$0.1 and Enzon Pharmaceuticals’s (ENZN) 200-day simple moving average is 0.11, creating a Sell signal.

Enzon Pharmaceuticals (ENZN) Technical Indicators

Sep 13, 2025, 06:09 PM
Name
Value
Implied Action
RSI (14)
44.79
Neutral
STOCH (9,6)
6.67
Buy
STOCHRSI (14)
6.67
Buy
MACD (12,26)
<0.01
Buy
ADX (14)
24.22
Neutral
Williams %R
-93.33
Buy
CCI (14)
-53.43
Neutral
ATR (14)
<0.01
-
Ultimate Oscillator
45.35
Neutral
ROC
0.00
Sell
Enzon Pharmaceuticals’s (ENZN) Relative Strength Index (RSI) is 44.79, creating a Neutral signal.
Enzon Pharmaceuticals’s (ENZN) Trend Strength Indicator (ADX) is 24.22, creating a Neutral signal.
Enzon Pharmaceuticals’s (ENZN) Commodity Channel Index (CCI) is -53.43, creating a Neutral signal.

FAQ

Is ENZN a Buy, Hold, or Sell?
Based on ENZN’s technical indicators, ENZN is a Sell.
    What is ENZN’s RSI (14)?
    ENZN’s RSI (14) is 44.79, which suggests ENZN is a Neutral.
      What is ENZN’s MACD?
      ENZN’s MACD is <0.01, which suggests ENZN is a Buy.
        What is ENZN’s 5-day moving average?
        ENZN’s 5-day moving average is 0.08, which suggests ENZN is a Sell.
          What is ENZN’s 20-day moving average?
          ENZN 20-day moving average is 0.08, which suggests ENZN is a Sell.
            What is ENZN’s 50-day moving average?
            ENZN’s 50-day moving average is 0.09, which suggests ENZN is a Sell.
              What is ENZN’s 200-day moving average?
              ENZN’s 200-day moving average is 0.11, which suggests ENZN is a Sell.
                What is ENZN’s Williams % R (14)?
                ENZN’s Williams % R (14) is -93.33, which suggests ENZN is a Buy.
                  What is ENZN’s CCI (14)?
                  ENZN’s CCI (14) is -53.43, which suggests ENZN is a Neutral.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis